Virtual reality to reduce discomfort during implantable port access – Full Text

“The use of VR helped reduce pain and/or discomfort in pediatric oncology patients, mainly in the older age group as they can better interact with VR. Healthcare providers were satisfied with the help of VR for TIVAD management” Caballero et al (2024).

Implantable port placement complications in pediatric hemophilia patients – Full Text

“This retrospective study at Beijing Children’s Hospital (2020-2023) analyzed surgical procedures and complications in 24 pediatric hemophilia patients undergoing Totally Implantable Venous Access Port (TIVAP) insertion, primarily in the right jugular vein (RJV)” Cheng et al (2024).

Oncology patients experience of implantable ports – Full Text

“The purpose of this study was to explore the psychological state and needs of tumor patients after implantation of an intravenous infusion port and provide valuable references for psychological interventions” Zhu et al (2024).

Implantable port-related long‑term complications – Full Text

“Therefore, in the present study, a predictive model for long-term complications following TIVAP implantation in patients with lung cancer was developed” Jia et al (2024).

Chemotherapy with implantable arterial access port – Full Text

“Following symptomatic treatment, the patient underwent a therapeutic regimen that combined transarterial infusion port FOLFOX-HAIC with Lenvatinib and Sintilimab” Jiang et al (2024).

Implantable port and PICC-related complications – Full Text

“Implantable venous access ports are safer than peripherally inserted central catheters for Chinese patients with hematological malignancies” Lu et al (2024).

PICC-port tunneling procedure

“Our data suggest pseudo-tunnelling is a safe and effective technique for PICC-Ports insertion avoiding central venous catheterization, even in patient with small vein at the arms” Benvenuti et al (2024).

Strategy for the removal of stuck implantable port

“The proposed stepwise interventional strategy successfully removed adherent port catheters, with good safety and high effectiveness. It appeared to reduce the incidence of catheter fracture during the removal of adherent totally implantable central venous access port catheters” Ding et al (2024).

Implantable port catheter tip location and complication rates

“The position of the catheter tip of totally implantable venous access devices (TIVAD) is a risk factor for postoperative complications. The study aim was to assess the early and late complications (EC and LC) associated with the position of the catheter tip in cancer patients” Hamri et al (2024).

Implantable port care standards

“This study aimed to determine the practices of nurses working in pediatric and adult oncology clinics regarding totally implantable venous access device (TIVAD) care” Gündogdu et al (2024).

Unplanned early implantable port removal – Full Text

“This study aims to determine the risk factors associated with unplanned (catheter removal other than completion of treatment plan) early (within 90 days of catheter implantation) implantable port catheter removal” Lu et al (2024).

Management of implantable port complications – Full Text

“Totally implanted venous access devices (TIVAD)/chemoports are indispensable in the management of cancer patients, especially in patients requiring long duration of infusion and prolonged treatment. Although chemoports are associated with a spectrum of complications, proper technique of implantation and use makes it a safe and reliable tool” Sharma and Pandey (2024).

FICC-ports – novel femoral implantable port

“In the last 3 years, we have implanted 47 FICC-ports in young adults with mediastinal lymphoma compressing the superior vena cava. We had no immediate/early complication, and only three late complications” Annetta et al (2024).

Implantable port site complications post bevacizumab infusion

“The results of this study show an inverse relationship between the risk of wound dehiscence and port site complication and the timing of bevacizumab infusion to port placement, with an increase in absolute risk of wound dehiscence when bevacizumab is given within 2 days of port placement” Yun et al (2024).

Totally implantable ports in infants and children – Full Text

“The type of port, including the material of the port’s venous catheter, and the underlying disease have an impact on the durability of implantable intravenous systems” Sosnowska-Sienkiewicz et al (2024).

Basilic vein variation during arm port placement – Full Text

“Basilic vein variation usually presents without any clinical symptoms and is often regarded as a benign alteration. This case was a patient with congenital basilic vein variation encountered during surgery for an infusion port” Hu et al (2024).

Implantable port insertion pocket-first technique – Full Text

“The pocket-first technique can be considered as a safe, feasible and convenient technique for TIVAP implantation. The time consuming is significantly shortened compared with the puncture-first technique and this advantage may be more obvious when using SCV/AxV approach” Wu et al (2024).

Patient experience with implanted venous access ports – Full Text

“The participants highlighted both the positive and negative aspects of venous access ports, while also identifying insufficient knowledge and “fear and anxiety” as barriers to accepting these devices” Janatolmakan et al (2024).

Ultrasound guided implantation of venous access ports – Full Text

“The aim of this study was to present demographic information of patients undergoing totally implantable venous access port (TIVAP) implantation and to investigate the rates of early and late complications, assessing the benefits of performing the procedure under US guidance” İlhan et al (2024).

Scarless totally implantable access port implantation – Full Text

“The scarless TIVAP implantation is a safe & reliable procedure with high patients-reported aesthetic satisfaction, and could be an alternative TIVAP procedure for patients requiring chemotherapy and desiring a less noticeable scar” Chang et al (2024).

Implantation of venous access port tip – Full Text

“To assess the safety and feasibility of intentionally positioning the catheter tip in the right atrium (RA) without an abutment during implantation of a totally implantable venous access port (TIVAP)” Park et al (2024).

Central venous ports for IV chemotherapy in infants – Full Text

“However, the feasibility and safety of the CVP for IVC in infants remain unknown. This study evaluated the usefulness of CVP for IVC in infants with retinoblastoma” Kubo et al (2024).

Radiation exposure during venous access port implantation

“pgrading the fluoroscopy equipment and completing two dedicated training courses allowed for a drastic decrease patient exposure to ionizing radiation during venous access port implantation by non-radiologist practitioners” Vallot et al (2024).

Implantable port infection risk

“In many patients with port infection, the ports are removed because antibiotics are ineffective. We evaluated the risk factors associated with port removal due to port infection” Hara et al (2024).

Implantable port infection and complication rates

“Double-lumen chest ports are associated with increased risk for bloodstream infection, malfunction, fibrin sheath formation, catheter tip malposition, and catheter-associated thrombosis” Kozlowski et al (2024).

Implantable port pocket infection risk

“Skin complications after the central venous port placement were related to cetuximab administration and the timing of cetuximab therapy” Sueyoshi et al (2024).

Implantable port or peripheral IV for CT contrast

“To evaluate the efficacy of using the central venous (CV) port compared with peripheral intravenous access for contrast-material injection for contrast enhancement during the portal venous phase” Washio et al (2024).

Implantable port CLABSI study – Full Text

“PORT implantation should be avoided in patients who had antibiotic treatment episodes within 1 week, especially for those with low serum TP levels” Chen et al (2023).

Implantable port position satisfaction survey – Full Text

“The port position should be chosen together with patients/caregivers based on the (dis-)advantages of each position, as identified by this study” van den Bosch et al (2024).

Improving knowledge and skills of implantable port patients

“The main objective of the study was to assess the impact of a pharmaceutical interview on patients’ knowledge and skills for patients with TIVAP” Nizet et al (2023).